Changmao Biochemical Engineering Co logo

954 - Changmao Biochemical Engineering Co Share Price

HK$0.6 0.0  0.0%

Last Trade - 27/11/20

Sector
Basic Materials
Size
Micro Cap
Market Cap £30.7m
Enterprise Value £18.6m
Revenue £47.5m
Position in Universe 4627th / 5954
Bullish
Bearish
Unlock 954 Revenue
Momentum
Relative Strength (%)
1m -9.53%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -33.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
561.7 514.8 594.4 630.8 639.1 494.6 -2.5%
-47.4 +22.8 -28.1 -84.5 +952.4 +15.8
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, ChangmaoBiochemical Engineering Co Ltd revenues decreased 26% toRMB219.9M. Net income decreased 64% to RMB15.2M. Revenuesreflect Europe segment decrease of 38% to RMB40.5M,Mainland China segment decrease of 16% to RMB124.8M. Netincome also reflects G/L on Sale of Tangible & IntangibleFA increase from RMB18K to RMB1.3M (expense), Governmentgrants decrease of 64% to RMB214K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

954 Revenue Unlock 954 Revenue

Net Income

954 Net Income Unlock 954 Revenue

Normalised EPS

954 Normalised EPS Unlock 954 Revenue

PE Ratio Range

954 PE Ratio Range Unlock 954 Revenue

Dividend Yield Range

954 Dividend Yield Range Unlock 954 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
954 EPS Forecasts Unlock 954 Revenue
Profile Summary

Changmao Biochemical Engineering Company Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of organic acids. The main products of the Company include organic acids and their derivatives with four carbons in structures. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L-tartaric acid, D-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. Its products are mainly sold to food additive industries, chemical industries and pharmaceutical industries. The Company operates businesses in Mainland China, Europe, Asia Pacific, America and other regions.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated December 3, 1992
Public Since June 28, 2002
No. of Shareholders: n/a
No. of Employees: 448
Sector Basic Materials
Industry Chemicals
Index
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 529,700,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
954 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 954
Upcoming Events for 954
Frequently Asked Questions for Changmao Biochemical Engineering Co
What is the Changmao Biochemical Engineering Co share price?

As of 27/11/20, shares in Changmao Biochemical Engineering Co are trading at HK$0.6, giving the company a market capitalisation of £30.7m. This share price information is delayed by 15 minutes.

How has the Changmao Biochemical Engineering Co share price performed this year?

Shares in Changmao Biochemical Engineering Co are currently trading at HK$0.6 and the price has moved by -23.08% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Changmao Biochemical Engineering Co price has moved by -31.33% over the past year.

What are the analyst and broker recommendations for Changmao Biochemical Engineering Co?

There are no analysts currently covering Changmao Biochemical Engineering Co.

When will Changmao Biochemical Engineering Co next release its financial results?

Changmao Biochemical Engineering Co is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Changmao Biochemical Engineering Co dividend yield?

The Changmao Biochemical Engineering Co dividend yield is 10.55% based on the trailing twelve month period.

Does Changmao Biochemical Engineering Co pay a dividend?

Last year, Changmao Biochemical Engineering Co paid a total dividend of 0.05, and it currently has a trailing dividend yield of 10.55%. Looking ahead, Changmao Biochemical Engineering Co has not announced an ex-dividend date yet.

When does Changmao Biochemical Engineering Co next pay dividends?

Changmao Biochemical Engineering Co has yet to annouce their ex-dividend date. The historic dividend yield on Changmao Biochemical Engineering Co shares is currently 10.55%.

How do I buy Changmao Biochemical Engineering Co shares?

To buy shares in Changmao Biochemical Engineering Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Changmao Biochemical Engineering Co?

Shares in Changmao Biochemical Engineering Co are currently trading at HK$0.6, giving the company a market capitalisation of £30.7m.

Where are Changmao Biochemical Engineering Co shares listed? Where are Changmao Biochemical Engineering Co shares listed?

Here are the trading details for Changmao Biochemical Engineering Co:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 954
What kind of share is Changmao Biochemical Engineering Co?

Based on an overall assessment of its quality, value and momentum, Changmao Biochemical Engineering Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Changmao Biochemical Engineering Co share price forecast 2020?

We were not able to load any forecast data for Changmao Biochemical Engineering Co.

How can I tell whether the Changmao Biochemical Engineering Co share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Changmao Biochemical Engineering Co. Over the past six months, the relative strength of its shares against the market has been -23.54%. At the current price of HK$0.6, shares in Changmao Biochemical Engineering Co are trading at -9.39% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Changmao Biochemical Engineering Co PE Ratio?

The Changmao Biochemical Engineering Co PE ratio based on its reported earnings over the past 12 months is 8.15. The shares are currently trading at HK$0.6.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Changmao Biochemical Engineering Co?

Changmao Biochemical Engineering Co's management team is headed by:

Xin Sheng Rui - CHM
Xian Biao Zeng - NED
Xiao Ping Yu - NED
Yi Xin Leng - NED
Chun Pan - CEO
Pui Ling Wan - SEC
A. Xing Lu - OTH
Yi Dong Wan - DGM
Jian Ping Wang - NED
Fung Lan Au - NID
Qin Ying Zhang - OTH
Who are the major shareholders of Changmao Biochemical Engineering Co?

Here are the top five shareholders of Changmao Biochemical Engineering Co based on the size of their shareholding:

Rui (Xin Sheng) Individual Investor
Percentage owned: 2.05% (3.77m shares)
Yu (Xiao Ping) Individual Investor
Percentage owned: 1.43% (2.62m shares)
Leng (Yi Xin) Individual Investor
Percentage owned: 0.03% (52.0k shares)
Similar to 954
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.